Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2004
03/18/2004WO2004022665A1 Two-photon absorption materials
03/18/2004WO2004022541A1 1,4-substituted cyclohexane derivatives
03/18/2004WO2004022540A2 Pyridazinone and pyridone derivatives as adenosine antagonists
03/18/2004WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use
03/18/2004WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers
03/18/2004WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors
03/18/2004WO2004022526A1 Cathepsin cysteine protease inhibitors
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004022056A1 Medicinal composition and method for treating malignant tumor and utilization thereof
03/18/2004WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors
03/18/2004WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor
03/18/2004WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions
03/18/2004WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain
03/18/2004WO2004002482A3 2-pyridin acetic acid derivatives with antiproliferative activity
03/18/2004WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction
03/18/2004WO2003097576A3 Diamino-functional chalcones
03/18/2004WO2003095421A8 Amino acid analogues
03/18/2004WO2003066595A3 2 - piperazine - pyridines useful for treating pain
03/18/2004US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders
03/18/2004US20040054132 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention
03/18/2004US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders
03/18/2004US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
03/18/2004US20040053971 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053935 Anticancer agents
03/18/2004US20040053934 Anticancer agents
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053932 Peptide deformylase inhibtors
03/18/2004US20040053914 Substituted piperzino-pyridine compound, useful for treting pain, anxiety, urinary incontinence, an addictive disorder, Parkinson's disease, epilepsy, psychosis, and used as Selective antagonists of the metabotropic glutamate receptor 5
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053786 Insecticidal 1,8-naphthalenedicarboxamides
03/18/2004US20040053382 Oxidizing an alpha-amino-carboxylic acid, hydrate, or salt thereof using a L-amino acid deaminase or oxidase and subsequently reducing the product thereof using a dehydrogenase
03/18/2004CA2501924A1 Non-nucleoside reverse transcriptase inhibitors
03/18/2004CA2499380A1 Novel vinyl carboxylic acid derivatives and their therapeutical use
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2495939A1 Cathepsin cysteine protease inhibitors
03/18/2004CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers
03/17/2004EP1398024A2 Uses for thyroid hormone compounds
03/17/2004EP1397505A2 Characterising polypeptides
03/17/2004EP1397355A1 Pyridyl cyanoguanidine compounds
03/17/2004EP1186596B1 Process for the production of 2-pyridylpyridine derivatives
03/17/2004EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
03/17/2004EP0891332B1 6-phenylpyridyl-2-amine derivatives
03/17/2004CN1483043A Chitosan-containing multicomponent composition and process for preparing the same
03/17/2004CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders
03/17/2004CN1482912A Heteroaryl urea neuropeptide yy5 receptor antagonists
03/17/2004CN1482907A Compounds having fungicidal activity and processes to make and use same
03/17/2004CN1142149C Novel pyridazine derivatives and drugs containing same as active ingredient
03/17/2004CN1142148C Pyridazine derivatives and drugs containing the same as the active ingredient
03/17/2004CN1142145C Process for preparation of 2,3-pyridine dicarboxylic acid
03/17/2004CN1142144C 4-phenyl pyridine derivatives
03/17/2004CN1142143C Process for synthesizing trident pyridinimine ligand
03/17/2004CN1142134C Processes for preparing pesticidal intermediates
03/16/2004US6706885 Process for preparing integrin antagonist intermediates
03/16/2004US6706884 Reacting 2-methyl-3-(tert-butylthio)pyridine derivative with aminoalkyl disulfide derivative; sulfiding in strong amide base
03/16/2004US6706829 Methods of polymerizing ethylene and styrene copolymers with substituted pyridyl amine catalysts and catalysts therefor
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004US6706741 Acetylcholinesterase inhibitors containing 1-benzyl-pyridinium salts
03/16/2004US6706740 Controlling, prevention fungi infections
03/16/2004US6706729 A method for dissociating a metal ion from a zinc finger-containing protein; inhibiting virus
03/16/2004US6706725 Vitamin D analogues
03/16/2004US6706715 Reversible inhibitors of the blood clotting enzyme factor viia
03/16/2004US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/16/2004US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone
03/11/2004WO2004020729A1 Method for delivering biologically active substances
03/11/2004WO2004020547A1 Reactive dendrimers
03/11/2004WO2004020448A1 Neutral metallic dendrimer complexes
03/11/2004WO2004020416A2 Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides
03/11/2004WO2004020414A1 Oxytocin inhibitors
03/11/2004WO2004020401A1 Synthesis of sulfonamide derivatives
03/11/2004WO2004020393A1 Dibenzylamine compound and medicinal use thereof
03/11/2004WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors
03/11/2004WO2004019889A2 Inhibitors of post-amadori advanced glycation end products
03/11/2004WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004WO2004005279A3 Substituted anthranilic amide derivatives and methods of use
03/11/2004WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators
03/11/2004WO2003097587A3 Gelling agents
03/11/2004WO2003091264A3 Non nucleoside reverse transcriptase inhibitors
03/11/2004WO2003078420A3 Process for making chiral 1,4-disubstituted piperazines
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004WO2003038508A3 Metal complex-based electron-transfer mediators in dye-sensitized solar cells
03/11/2004WO2003018559A3 Intermediates and preparation thereof for the enantioselective synthesis of (20r) homocamptothecins
03/11/2004WO2003002524A3 Urea derivatives with antiproteolytic activity
03/11/2004US20040049083 Arylpiperazines having activity at the serotonin 1A receptor
03/11/2004US20040049072 RXR modulators with improved pharmacologic profile
03/11/2004US20040049048 Novel process
03/11/2004US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040048904 E.g., 1-(pyridin-4-ylcarbamoyl)-1,2,3,6- tetrahydropyridine hydrochloride; treating and/or preventing amnesia or dementia
03/11/2004US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
03/11/2004US20040048902 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
03/11/2004US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis
03/11/2004US20040048895 Caspase-1 inhibitors and methods for their use
03/11/2004US20040048894 Compounds which mimic the chemical and biological properties of discodermolide
03/11/2004US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
03/11/2004US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics.
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation